Applications of Biological Sciences in Nanotechnology for Targeted Drug Delivery Systems
Keywords:
Targeted drug delivery, nanotechnology, biological sciences, nanocarriers, ligand-targeting, biomimetic systems, controlled releaseAbstract
Targeted drug delivery systems (TDDS) represent a significant leap in precision medicine, aiming to maximize therapeutic efficacy while minimizing side effects. Nanotechnology, fused with advances in biological sciences, offers innovative tools to engineer nanoparticles capable of navigating complex biological environments. The integration of biologically inspired systems—such as ligand-receptor targeting, stimuli-responsive nanocarriers, and biomimetic delivery vectors—has enabled breakthroughs in site-specific delivery, particularly in oncology, neurology, and infectious diseases. The principles and mechanisms underpinning biological-nanotechnological integration for TDDS.
References
Couvreur, P., Kante, B., Roland, M., Guiot, P., Bauduin, P., Speiser, P. Polyalkylcyanoacrylate nanoparticles as colloidal drug carriers for intravenous administration: tolerance and activity of loaded drugs. J. Pharm. Sci. 69, 199–202 (1980)
Allen, T.M., Cullis, P.R. Drug delivery systems: entering the mainstream. Science 303, 1818–1822 (2004)
Torchilin, V.P. Recent advances with liposomes as pharmaceutical carriers. Nat. Rev. Drug Discov. 4, 145–160 (2005)
Kwon, G.S., Kataoka, K. Block copolymer micelles as long-circulating drug vehicles. Adv. Drug Deliv. Rev. 16, 295–309 (1995)
Zhang, L., Zhang, S., Feng, S.S. Nanoparticles and nanocarriers based on physiological lipids for drug delivery. J. Mater. Sci. Mater. Med. 19, 2311–2320 (2008)
Ferrari, M. Cancer nanotechnology: opportunities and challenges. Nat. Rev. Cancer 5, 161–171 (2005)
Peer, D., Karp, J.M., Hong, S., Farokhzad, O.C., Margalit, R., Langer, R. Nanocarriers as an emerging platform for cancer therapy. Nat. Nanotechnol. 2, 751–760 (2007)
Davis, M.E., Chen, Z., Shin, D.M. Nanoparticle therapeutics: an emerging treatment modality for cancer. Nat. Rev. Drug Discov. 7, 771–782 (2008)
Liu, Y., Miyoshi, H., Nakamura, M. Nanomedicine for drug delivery and imaging: a promising avenue for cancer therapy and diagnosis. Cancer Sci. 98, 1247–1252 (2007)
Sahoo, S.K., Labhasetwar, V. Nanotech approaches to delivery and imaging drug. Drug Discov. Today 8, 1112–1120 (2003)
Petros, R.A., DeSimone, J.M. Strategies in the design of nanoparticles for therapeutic applications. Nat. Rev. Drug Discov. 9, 615–627 (2010)
Jokerst, J.V., Gambhir, S.S. Molecular imaging with theranostic nanoparticles. Acc. Chem. Res. 44, 1050–1060 (2011)
Prasad, R., Kumar, V., Patel, M.K. Nanotechnology in sustainable agriculture: Present concerns and future aspects. Afr. J. Biotechnol. 13, 705–713 (2014)
Mitragotri, S., Burke, P.A., Langer, R. Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies. Nat. Rev. Drug Discov. 13, 655–672 (2014)
Maeda, H., Bharate, G.Y., Daruwalla, J. Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect. Eur. J. Pharm. Biopharm. 71, 409–419 (2009)
Cho, K., Wang, X., Nie, S., Chen, Z.G., Shin, D.M. Therapeutic nanoparticles for drug delivery in cancer. Clin. Cancer Res. 14, 1310–1316 (2008)
Alexis, F., Rhee, J.W., Richie, J.P., Radovic-Moreno, A.F., Langer, R., Farokhzad, O.C. New frontiers in nanotechnology for cancer treatment. Urol. Oncol. 26, 74–85 (2008)
Gao, H., Pang, Z., Jiang, X. Targeted delivery of nano-therapeutics for major disorders of the central nervous system. Pharm. Res. 30, 2485–2498 (2013)
Kannan, R.M., Nance, E., Kannan, S., Tomalia, D.A. Emerging concepts in dendrimer-based nanomedicine: from design principles to clinical applications. J. Intern. Med. 276, 579–617 (2014)
Jain, R.K., Stylianopoulos, T. Delivering nanomedicine to solid tumors. Nat. Rev. Clin. Oncol. 7, 653–664 (2010).
Downloads
Published
Issue
Section
License
Copyright (c) 2020 Lachlan William (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
